MANH

Financial Results Announcement: Manhattan Associates Inc. will release its first quarter 2025 financial results on April 22, 2025, followed by a conference call at 4:30 p.m. Eastern time, which can be accessed via their Investor Relations website.

Company Overview: Manhattan Associates is a global leader in supply chain and omnichannel commerce technology, providing innovative software solutions that enhance both sales and supply chain execution for businesses.

Class Action Filed: A class action lawsuit has been initiated against Manhattan Associates, Inc. for allegedly misleading investors about its growth potential and revenue forecasts during the period from October 22, 2024, to January 28, 2025.

Stock Price Decline: Following the announcement of reduced revenue guidance on January 28, 2025, Manhattan Associates' stock price dropped over 24%, prompting shareholders to consider participating in the class action or serving as lead plaintiffs by April 28, 2025.

Class Action Lawsuit Filed: A class action lawsuit has been initiated against Manhattan Associates, Inc. for alleged violations of federal securities laws during the period from October 22, 2024, to January 28, 2025, with investors having until April 28, 2025, to seek lead plaintiff status.

Allegations and Stock Impact: The lawsuit claims that the company misrepresented its revenue outlook and growth potential, leading to a significant drop in stock price after disappointing financial results were announced on January 28, 2025, causing a 25% decline in share value.

Recognition in Transportation Management: Manhattan Associates has been named a Leader in the Gartner Magic Quadrant for Transportation Management Systems for the seventh consecutive year, highlighting its innovative cloud-native technology and unified supply chain execution solutions that enhance visibility and efficiency in complex logistics environments.

Technological Advancements: The latest updates to Manhattan's platform include GenAI capabilities and integration with Yard Management and Warehouse Management systems, providing businesses with a comprehensive and adaptable supply chain execution system that optimizes operations beyond traditional siloed offerings.

Class Action Lawsuit Filed: A class action lawsuit has been initiated against Manhattan Associates, Inc. for alleged violations of federal securities laws, targeting investors who purchased the company's securities between October 22, 2024, and January 28, 2025.

Financial Disclosures Impact Stock Price: Following disappointing financial results and forecasts released on January 28, 2025, Manhattan Associates' stock price dropped significantly, leading to further declines after the announcement of CEO Eddie Capel's retirement.

Investor Alert: Faruqi & Faruqi, LLP is investigating potential claims against Manhattan Associates, Inc. for alleged violations of federal securities laws related to misleading statements about the company's revenue forecasts, with a deadline of April 28, 2025, for investors to seek lead plaintiff status in a class action lawsuit.

Stock Price Decline: Following the announcement of reduced revenue guidance on January 28, 2025, Manhattan Associates' stock price fell approximately 24.49% in one day, prompting the firm to encourage affected investors to discuss their legal options.

Class Action Lawsuits Announced: Bragar Eagel & Squire, P.C. has initiated class action lawsuits for stockholders of Skyworks Solutions, Maravai LifeSciences, Rocket Lab USA, and Manhattan Associates, with deadlines for lead plaintiff petitions set for May 5 and April 28, 2025.

Allegations of Misleading Information: Each company is accused of providing materially false or misleading statements regarding their financial performance and operational prospects, leading to significant declines in stock prices following negative announcements.

iShares MSCI USA Quality Factor ETF Analysis: The iShares MSCI USA Quality Factor ETF (QUAL) has an implied analyst target price of $207.70, indicating a potential upside of 20.57% from its current trading price of $172.26.

Notable Holdings with Upside Potential: Key underlying holdings such as Manhattan Associates (MANH), NetApp (NTAP), and Horton Inc (DHI) show significant upside potential, with analysts projecting increases of 38.30%, 33.94%, and 32.56% respectively from their recent prices.

Securities Fraud Class Action: Bernstein Liebhard LLP is reminding investors of Manhattan Associates, Inc. about a class action lawsuit alleging securities fraud due to misrepresentations regarding the company's growth forecasting capabilities, with a deadline for lead plaintiff applications set for April 28, 2025.

Investor Rights and Legal Options: Shareholders who purchased shares between October 22, 2024, and January 28, 2025, are encouraged to discuss their legal rights and options, with representation available on a contingency fee basis.

Investor Alert: Faruqi & Faruqi, LLP is investigating potential claims against Manhattan Associates, Inc. for investors who suffered losses exceeding $100,000 between October 22, 2024, and January 28, 2025, urging them to contact partner Josh Wilson for legal options.

Class Action Details: A federal securities class action has been filed against Manhattan Associates due to alleged violations of federal securities laws, with a deadline of April 28, 2025, for investors to seek the role of lead plaintiff following a significant stock price drop after the company announced reduced revenue guidance.

Investor Losses and Legal Action: Faruqi & Faruqi, LLP is encouraging investors who suffered losses exceeding $100,000 in Manhattan Associates between October 22, 2024, and January 28, 2025, to contact them regarding potential legal claims and the upcoming April 28, 2025 deadline for lead plaintiff applications in a federal securities class action.

Allegations Against Manhattan Associates: The firm is investigating allegations that Manhattan Associates and its executives made misleading statements about the company's revenue expectations, leading to a significant drop in stock price after the announcement of reduced revenue guidance on January 28, 2025.

Class Action Lawsuit Filed: A class action lawsuit has been initiated against Manhattan Associates, Inc. for alleged violations of federal securities laws, affecting investors who purchased shares between October 22, 2024, and January 28, 2025.

Financial Disclosures Impact Stock Price: Following disappointing financial results and forecasts, including a significant drop in services revenue and the announcement of CEO Eddie Capel's retirement, Manhattan Associates' stock price experienced substantial declines.

Class Action Lawsuits Announced: Bragar Eagel & Squire, P.C. has initiated class action lawsuits for stockholders of Skyworks Solutions, Maravai LifeSciences, AppLovin Corporation, and Manhattan Associates, with deadlines for lead plaintiffs set for May 5, 2025, and April 28, 2025.

Stock Price Declines Due to Misleading Information: Each company faced significant stock price drops following announcements of disappointing financial results or revelations of misleading statements regarding revenue expectations and internal controls, leading to allegations of false information provided to investors.

Class Action Lawsuit Filed: A class action lawsuit has been initiated against Manhattan Associates, Inc. for investors who acquired its securities between October 22, 2024, and January 28, 2025, with a deadline of April 28, 2025, to apply as lead plaintiff.

Financial Results Impact: Following the announcement of disappointing financial results and lowered revenue guidance on January 28, 2025, Manhattan's stock price dropped by approximately 24%, raising allegations that the company misrepresented its forecasting capabilities during the class period.

Securities Fraud Class Action: Bernstein Liebhard LLP is reminding investors of Manhattan Associates, Inc. about a securities fraud class action lawsuit filed against the company for alleged misrepresentations regarding its growth forecasting capabilities, affecting those who purchased shares between October 22, 2024, and January 28, 2025.

Lead Plaintiff Deadline: Investors wishing to serve as lead plaintiffs must file by April 28, 2025, with all representation on a contingency fee basis, meaning shareholders incur no fees or expenses unless there is a recovery.

Investor Alert: Faruqi & Faruqi, LLP is encouraging investors who suffered losses over $100,000 in Manhattan Associates between October 22, 2024, and January 28, 2025, to contact partner Josh Wilson for legal options regarding a federal securities class action against the company.

Class Action Details: The firm is investigating claims that Manhattan Associates made misleading statements about its revenue forecasts, leading to a significant drop in stock price after the announcement of reduced revenue guidance on January 28, 2025.

Class Action Lawsuits Announced: Bragar Eagel & Squire, P.C. has initiated class action lawsuits for stockholders of Skyworks Solutions, Maravai LifeSciences, and Manhattan Associates, with deadlines for lead plaintiff petitions approaching in May and April 2025.

Stock Price Declines Following Financial Disclosures: Each company experienced significant stock price drops after revealing disappointing financial results and operational challenges, leading to allegations of misleading statements regarding their business prospects.

Class Action Lawsuit Filed: A class action lawsuit has been initiated against Manhattan Associates, Inc. for alleged violations of federal securities laws, targeting investors who purchased the company's securities between October 22, 2024, and January 28, 2025.

Financial Disclosures Impact Stock Price: Following disappointing financial results and forecasts, including a significant drop in services revenue and a decline in expected earnings per share, Manhattan Associates' stock price fell sharply, leading to further leadership changes within the company.

Legal Action Encouragement: Faruqi & Faruqi, LLP is urging investors who suffered losses from Manhattan Associates between October 22, 2024, and January 28, 2025, to contact partner Josh Wilson for legal options, especially with an April 28, 2025 deadline approaching for lead plaintiff applications in a federal securities class action.

Allegations Against Manhattan Associates: The firm is investigating claims that Manhattan Associates made misleading statements regarding its revenue forecasts, leading to a significant stock price drop of approximately 24.49% following the release of disappointing financial results on January 28, 2025.

Retail Performance Insights: The 2025 Unified Commerce Benchmark for Specialty Retail reveals that only 5% of assessed retailers achieved Leader status, with top performers like Apple and Nike demonstrating significant revenue growth and customer satisfaction through enhanced omnichannel experiences.

Evolving Consumer Expectations: Key areas defining retail leadership by 2025 include a seamless shopping experience across channels, reimagined checkout processes, flexible fulfillment options, and unified customer service, all driven by insights and advanced technologies like GenAI.